UBS AM’s Apigee Corporation Common Stock APIC Stock Holding History

UBS AM’s Portfolio APIC Stock Details APIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-543,514	Closed	-$9.46M	–	2824
2016 Q3	$9.46M	Sell	543,514 -307,564	-36%	-$4.49M	0.01%	894
2016 Q2	$10.4M	Buy	851,078 +199,857	+31%	+$2.12M	0.01%	869
2016 Q1	$5.41M	Buy	651,221 +3,327	+0.5%	+$24.8K	0.01%	1004
2015 Q4	$5.2M	Sell	647,894 -57,822	-8%	-$504K	0.01%	1063
2015 Q3	$7.45M	Buy	705,716 +398,742	+130%	+$3.46M	0.01%	946
2015 Q2	$3.05M	Buy	+306,974	New	+$4.21M	﹤0.01%	1224

UBS AM's APIC Position: Q4 2016 in Review

UBS AM sold out of Apigee Corporation Common Stock (APIC) in Q4 2016, closing a stake of 543,514 shares — an estimated $9.46M sold.

UBS AM first reported a position in APIC in Q2 2015 and held it in 6 quarters. The position peaked at $10.4M in Q2 2016. 0 funds tracked by Wall St. Rank hold APIC as of Q4 2016.

UBS AM reported no remaining Apigee Corporation Common Stock position as of Q4 2016 after selling out during the quarter.
UBS AM sold 543,514 Apigee Corporation Common Stock shares in Q4 2016, an estimated $9.46M.
UBS AM first reported a position in Apigee Corporation Common Stock in Q2 2015 and held it in 6 quarters.
UBS AM's Apigee Corporation Common Stock position peaked at $10.4M in Q2 2016.
0 funds tracked by Wall St. Rank held Apigee Corporation Common Stock as of Q4 2016.

Based on UBS AM's 13F filing for Q4 2016, filed 14 Feb 2017.